Dr. Renee Sullivan is board certified in Internal Medicine and Cardiovascular Disease and trained in Clinical Cardiac Electrophysiology. She is a Medical Director in the Cardiovascular, Metabolic, Endocrine, Renal therapeutic area at Covance. She joined Covance in December 2014 and in this role is responsible for providing medical and scientific expertise, consultation and leadership for project teams and site investigators; designing and reviewing clinical trial protocols; and performing medical monitoring for clinical research trials. She serves as a Covance medical expert in cardiovascular, cardiac electrophysiology and device-based therapeutics.
Prior to joining Covance, Dr. Sullivan worked in academic practice during which time she was involved in clinical research. She is an invited national and international speaker for Continuing Medical Education courses, invited lectures, and society conferences. She is a Fellow of the American College of Cardiology and has served on various American College of Cardiology committees at the state and national levels. She is a member of the Heart Rhythm Society, European Cardiac Arrhythmia Society, and American Heart Association. She has published in the areas of anticoagulation in patients with atrial fibrillation (with an emphasis on gender differences), arrhythmias, and cardiac implantable electronic devices. Dr. Sullivan completed a combined BA/MD program at the University of Missouri- Kansas City and completed her residency and chief residency in Internal Medicine and fellowships in Cardiovascular Disease and Clinical Cardiac Electrophysiology at the University of Iowa Hospitals and Clinics.